BELLEVUE, Wash.—July 15, 2003 — Noetix Corp., a global infrastructure software provider that unlocks corporate data and empowers business users to answer their own questions, today announced that CTI Molecular Imaging Inc., a leading supplier of products and services for positron emission tomography (PET), is expanding the use of Noetix to its corporate manufacturing and service organizations.
"With Noetix, our business users are able to get information out of Oracle Applications without involving the IT organization," said Walter Cromer, director of IT Technology and Services. "Noetix delivers more information to line of business personnel and managers than our team could have ever done alone."
To date, Noetix has handled the majority of the CTI pharmaceuticals unit’s report requests, eliminating the time business users had to wait for IT staff to deliver those reports. Because Noetix enables business users to export reports into Microsoft Excel, the pharmaceutical unit’s users were able to work with a program familiar to them and take advantage of features and functions they already understood.
In the coming months, CTI will roll out the solution to the company’s manufacturing and service organizations to enable users to access information in real time and communicate crucial information to customers.
CTI first approached Noetix at the time the company implemented Oracle 11i in its pharmaceutical subsidiary. The IT department realized it needed an immediate solution to get business data out of Oracle in a timely and flexible manner. Due to rapid company growth, the pressure was on to find an out-of-the-box solution for extracting the data out of Oracle.
"Development resources were scarce, and we needed a way to put report generation into the users’ hands," said CTI Project Manager Troy Staton.
"We chose Noetix because it gave us what we needed — right off the bat. As a result, we were able to redeploy IT resources and focus on mission-critical tasks rather than support user report requests." Cromer said.
"CTI is another exciting example of how Noetix enables businesses to get more value from their existing enterprise application investments through better information," said Paul Song, CEO of Noetix. "We’re thrilled CTI has benefited from our software and will expand its use to meet the reporting requirements of its manufacturing and service organizations."
CTI Molecular Imaging, Inc. is a leading supplier of products and services for positron emission tomography (PET), a diagnostic imaging technology used in the detection and treatment of cancer, neurological disorders and cardiac disease. PET's whole-body imaging capability helps physicians improve their ability to determine the location, extent and stage of cancer, neurological disorders and cardiac disease.
Since 1983, the Company has been at the forefront of the innovation and technical advancement of PET. CTI introduced the first commercial high-resolution PET scanner and is responsible for the development of most of the major commercial innovations in PET. In 1992, CTI developed the first whole body imaging capability, and, in 1998, CTI invented the combination PET/CT scanner. Today, CTI is the only manufacturer of scanners with proprietary LSO-based detectors, which reduce the duration of a PET scan by at least 50% compared to the prior technology. CTI continues to develop PET products and services that lead to earlier, more accurate diagnosis and improved therapy management.
Noetix provides global infrastructure software to unlock corporate data, enabling companies to manage the secure distribution of business data across the wired and wireless Internet. Corporations using the Noetix solution can automatically map complex, fragmented data and translate it into understandable business terms. Noetix technology is easy to implement, works with existing tools and is extensible due to its open architecture. Noetix has more than 1,000 customers including Motorola, Starbucks, Toshiba, Tupperware and Visa. The company is headquartered in Bellevue, Wash., with international operations based in London. For more information about Noetix, visit the Web site at www.noetix.com or call toll free at 866-4NOETIX.
Revolution Public Relations